Average Co-Inventor Count = 7.30
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Eisai Company, Limited (15 from 677 patents)
2. Eisai R&d Management Co., Ltd. (3 from 529 patents)
18 patents:
1. 7994154 - Substituted liposaccharides useful in the treatment and prevention of endotoxemia
2. 7737129 - Substituted liposaccharides useful in the treatment and prevention of endotoxemia
3. 7304083 - 2-iminoimidazole derivatives (2)
4. 6841549 - Condensed imidazole compounds and a therapeutic agent for diabetes mellitus
5. 5935938 - Substituted liposaccharides useful in the treatment and prevention of
6. 5843918 - Anti-endotoxin compounds
7. 5756718 - Anti-endotoxin compounds
8. 5750664 - Substituted liposaccharides useful in the treatment and prevention of
9. 5681824 - Substituted liposaccharides useful in the treatment and prevention of
10. 5612476 - Anti-endotoxin compounds
11. 5530113 - Anti-endotoxin compounds
12. 5476863 - Glycerin derivative and its pharmacological use
13. 5476864 - Glycerin derivative and its pharmacological use
14. 5273985 - Glycerin derivative and its pharmacological use
15. 5075335 - Guanidinobenzoic ester derivative